Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (GDRX) operates a leading digital healthcare platform that transforms prescription affordability through price transparency tools and pharmacy benefit solutions. This news hub provides investors and industry professionals with essential updates on financial performance, strategic initiatives, and regulatory developments impacting the company’s role in reshaping medication access.
Discover official press releases covering quarterly earnings, partnership announcements with healthcare stakeholders, and expansions of the company’s prescription savings ecosystem. Our curated collection includes analyses of market trends affecting GoodRx’s position in digital health, updates on telehealth integrations, and coverage of consumer affordability programs.
Key updates include developments in PBM collaborations, Medicare/Medicaid pricing initiatives, and technological advancements within the GoodRx platform. Bookmark this page to monitor how the company navigates evolving healthcare regulations while maintaining its mission to reduce out-of-pocket medication costs for millions of Americans.
GoodRx (NASDAQ: GDRX) released a report indicating that expanding pharmacist prescribing authority significantly enhances access to critical medications, especially for PrEP (HIV prevention pill). The report highlights an increase in PrEP fills by 24% after one year and 110% after two years in states that allow pharmacists to prescribe. Over 37 million Americans reside in under-resourced areas where pharmacist authority could enhance healthcare access. GoodRx emphasizes that improved access leads to better medication adherence, benefiting both patients and healthcare providers.
GoodRx Holdings, Inc. (Nasdaq: GDRX), a digital healthcare platform, will present at two upcoming investor conferences. The first is the Credit Suisse 31st Annual Healthcare Conference on November 10 in Rancho Palos Verdes, CA, at 9:50 a.m. Pacific Time. The second is the Wells Fargo 6th Annual TMT Summit on December 1 in Las Vegas, NV, at 8:40 a.m. Pacific Time. Live webcasts and archived recordings will be available on the Company's Investor Relations website. GoodRx has saved consumers over $40 billion since 2011 and is among the most downloaded medical apps in the past decade.
GoodRx has launched Provider Mode, a dedicated platform for healthcare providers aimed at reducing administrative workload while facilitating patient access to medications. Since June 2021, over 850,000 prescribers have utilized GoodRx for medication pricing and discounts. With a 90% net promoter score among providers, the tool offers features like cost comparison, a dashboard for easy access to resources, and savings programs. Additionally, partnerships with companies like Biogen enhance its offerings to streamline processes for specialty therapies.
GoodRx (NASDAQ: GDRX) has launched a new feature called Provider Mode, designed to streamline the enrollment process for healthcare providers (HCPs) prescribing VUMERITY® (diroximel fumarate) for relapsing multiple sclerosis. This digital form helps reduce paperwork and errors, significantly speeding up patient treatment initiation. Since its rollout, Provider Mode has achieved a 90% opt-in rate from providers, with Biogen (NASDAQ: BIIB) being the first pharmaceutical partner to use this system. This collaboration aims to enhance patient care by simplifying the therapy start process.
GoodRx Holdings Inc. (GDRX) will release its Q3 2022 financial results on November 8, 2022, after U.S. market close. A conference call and webcast are scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss these results and provide business insights. GoodRx, a digital healthcare platform, has saved consumers over $40 billion since its launch in 2011. Investors can access the live call and archived materials on the Company’s investor relations website.
GoodRx (NASDAQ: GDRX) is offering free online healthcare provider visits to Florida residents affected by Hurricane Ian until October 17, using the code FL-CARE-100. This initiative aims to ensure residents can access essential healthcare services amidst the ongoing recovery challenges. GoodRx Care allows for consultations for various conditions and medication refills, aiding those impacted by the disaster. The platform is focused on making healthcare affordable and convenient, having saved consumers over $40 billion since its inception in 2011.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA, on Thursday, September 15, at 11:30 a.m. PT (2:30 p.m. ET). A live webcast will be available on the Company's Investor Relations website. GoodRx, a digital healthcare platform, has helped consumers save over $40 billion since 2011, providing affordable healthcare solutions. Archived recordings of the presentation will be accessible for at least 30 days post-conference.
GoodRx (NASDAQ: GDRX) is offering free online healthcare visits for Kentucky residents affected by recent flooding using the code KY-CARE-100. Available until August 31, 2022, this service allows individuals to consult licensed medical providers for various conditions and refill medications lost during the disaster. The initiative aims to support Kentuckians struggling to access healthcare during this challenging time. GoodRx has helped consumers save over $40 billion since its inception in 2011, emphasizing its commitment to affordable healthcare.
GoodRx Holdings, Inc. (Nasdaq: GDRX) announced that its management will present virtually at the Bank of America SMID Cap Ideas Conference on August 10 at 8:20 a.m. Pacific Time. A live webcast will be accessible on the Company’s Investor Relations website, with an archived recording available for 30 days after the event. GoodRx, a leading digital healthcare platform, has helped consumers save over $40 billion since 2011 and is among the most downloaded medical apps.